J&J coronavirus vaccine appears to protect against Delta variant
Johnson & Johnson announced that its COVID-19 vaccine “”generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.” The vaccine was developed in a collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch. Read Article